| Lung Large Cell Carcinoma studied in …STUDIED_INderived33 of 33show fewer |
|---|
| → studied in | NCT05198830Phase 2 · active not recruiting Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386385Phase 1/Phase 2 · active not recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186847Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06996249recruiting Prospective Data Collection Initiative on Thoracic Malignancies · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642251Phase 1/Phase 2 · completed Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110978Phase 2 · active not recruiting Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01345851NA · active not recruiting Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566223Phase 1/Phase 2 · withdrawn CISH Inactivated TILs in the Treatment of NSCLC · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03845296Phase 2 · completed Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) · condition mapped CURATED_BROADER · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264210Phase 2 · completed Icotinib for Completed Resected IB NSCLC With EGFR Mutation · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946712Phase 3 · terminated S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535325Phase 1 · completed Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01958372Phase 1 · completed Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00950365Phase 2 · completed Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03305133completed Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02134912Phase 2 · terminated S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01557959Phase 2 · completed Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00955305Phase 2 · terminated Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01294306Phase 2 · completed MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00368992Phase 2 · completed S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059967Phase 1 · withdrawn Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049543Phase 3 · completed Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01668823Phase 1 · completed Photodynamic Therapy in Treating Patients With Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369551Phase 1 · terminated Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002852Phase 3 · completed Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040794Phase 2 · completed Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118183Phase 2 · completed Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087412Phase 2 · completed S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020709Phase 3 · completed Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021060Phase 2/Phase 3 · completed Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042835Phase 1 · terminated Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005838Phase 3 · completed Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |